Copper-based Microbiome Modulation for Diverse Health Applications

Publication ID: 24-11857675_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Copper-based Microbiome Modulation for Diverse Health Applications,” Published Technical Disclosure No. 24-11857675_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857675_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,675.

Summary of the Inventive Concept

A novel approach to leveraging copper's antimicrobial properties to develop innovative solutions for various health issues, including respiratory diseases, cognitive function, skin diseases, eye diseases, and athletic performance.

Background and Problem Solved

The original patent disclosed a method for reducing HPV incidence and prevalence by modifying the cervical microbiome. However, this technology has untapped potential for addressing other significant health concerns. The new inventive concept expands on this core technology to tackle unmet needs in diverse fields, providing a comprehensive solution for various diseases and health issues.

Detailed Description of the Inventive Concept

The new inventive concept encompasses a range of copper-based devices and systems designed to modulate the microbiome in different parts of the body. For instance, a respiratory device with a surface area between 100 mm2 to 200 mm2 can be used to reduce the incidence of respiratory diseases by modifying the respiratory microbiome. Similarly, a wearable device with a surface area between 50 mm2 to 100 mm2 can enhance cognitive function by increasing local immunity in the brain. Other embodiments include skin patches, eye masks, and athletic performance-enhancing devices, all leveraging copper's antimicrobial properties to address specific health concerns.

Novelty and Inventive Step

The new claims introduce a paradigm shift by applying the core technology to entirely new fields and use cases, demonstrating a non-obvious expansion of the original patent's concepts. The inventive step lies in recognizing the broader potential of copper-based microbiome modulation and adapting it to address diverse health issues.

Alternative Embodiments and Variations

Alternative embodiments could include the use of different materials or geometries for the devices, as well as varying surface areas or configurations to optimize performance. Additionally, the concept could be extended to other health applications, such as wound healing or gastrointestinal health, further broadening its scope.

Potential Commercial Applications and Market

The copper-based microbiome modulation technology has vast commercial potential, with applications in various industries, including healthcare, wellness, sports, and cosmetics. The target market includes individuals seeking preventative measures or treatments for respiratory diseases, cognitive function, skin diseases, eye diseases, and athletic performance enhancement, as well as companies looking to integrate this technology into their products or services.

CPC Classifications

SectionClassGroup
A A61 A61K9/0039
A A61 A61F6/144
A A61 A61K33/34

Original Patent Information

Patent NumberUS 11,857,675
TitleMethod for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections